BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22594512)

  • 1. Pharmacogenomics and public health: implementing 'populationalized' medicine.
    Mette L; Mitropoulos K; Vozikis A; Patrinos GP
    Pharmacogenomics; 2012 May; 13(7):803-13. PubMed ID: 22594512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacogenomics and the path towards personalized medicine].
    Belloso WH; Redal MA
    Medicina (B Aires); 2010; 70(3):265-74. PubMed ID: 20529779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.
    Wong SH; Happy C; Blinka D; Gock S; Jentzen JM; Donald Hon J; Coleman H; Jortani SA; Lucire Y; Morris-Kukoski CL; Neuman MG; Orsulak PJ; Sander T; Wagner MA; Wynn JR; Wu AH; Yeo KT
    Pharmacogenomics; 2010 Jun; 11(6):731-7. PubMed ID: 20504247
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
    Lesko LJ; Zineh I
    Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacogenomics].
    Nakatani K; Nobori T
    Rinsho Byori; 2013 Nov; 61(11):1018-25. PubMed ID: 24450107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One size fits one: pharmacogenetics in gastroenterology.
    Porayette P; Flockhart D; Gupta SK
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics and active surveillance for serious adverse drug reactions in children.
    Loo TT; Ross CJ; Sistonen J; Visscher H; Madadi P; Koren G; Hayden MR; Carleton BC
    Pharmacogenomics; 2010 Sep; 11(9):1269-85. PubMed ID: 20860467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
    Low SK; Takahashi A; Mushiroda T; Kubo M
    Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving the promise of personalized medicine.
    Reynolds KS
    Clin Pharmacol Ther; 2012 Oct; 92(4):401-5. PubMed ID: 22992663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic biomarkers for personalized medicine.
    Chen JJ; Lin WJ; Chen HC
    Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in pharmacogenomics and its promise for medicine.
    Blake CA; Sobel BE
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.
    Squassina A; Manchia M; Manolopoulos VG; Artac M; Lappa-Manakou C; Karkabouna S; Mitropoulos K; Del Zompo M; Patrinos GP
    Pharmacogenomics; 2010 Aug; 11(8):1149-67. PubMed ID: 20712531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics: questions and concerns.
    Mahlknecht U; Voelter-Mahlknecht S
    Curr Med Res Opin; 2005 Jul; 21(7):1041-7. PubMed ID: 16004671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics in children.
    Rieder M
    Methods Mol Biol; 2014; 1175():687-707. PubMed ID: 25150881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research.
    Kennedy MA; Joyce PR; Begg EJ
    Pharmacogenomics; 2012 Jun; 13(8):865-8. PubMed ID: 22676191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4th Annual Pharmacogenomics and Medicine Lectures.
    Oestreicher P
    Pharmacogenomics; 2001 Aug; 2(3):291-6. PubMed ID: 11939134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenomics: hype or hope?].
    Schwab M; Schaeffeler E; Zanger UM; Brauch H; Kroemer HK
    Dtsch Med Wochenschr; 2011 Mar; 136(10):461-7. PubMed ID: 21365522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Introductory remarks by chairpersons].
    Kumagai S; Nobori T
    Rinsho Byori; 2013 May; 61(5):419-20. PubMed ID: 23947181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
    Wei CY; Lee MT; Chen YT
    Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of pharmacoproteomics in the development of personalized medicine.
    Jain KK
    Pharmacogenomics; 2004 Apr; 5(3):331-6. PubMed ID: 15102547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.